Asthma  >>  Pulmicort Turbuhaler (budesonide dry-powder inhaler)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pulmicort Turbuhaler (budesonide dry-powder inhaler) / AstraZeneca
NCT00989833 / 2009-012805-20: Comparing Symbicort® As-Needed or Bricanyl As-Needed or Pulmicort® Once Daily + Bricanyl As-Needed in Asthma Patients

Completed
2
66
Europe
budesonide, Pulmicort Turbuhaler, terbutaline, Bricanyl Turbuhaler, budesonide/formoterol, Symbicort Turbuhaler
AstraZeneca
Exercise Induced Asthma
07/10
07/10
2006-000038-11: EVALUATION OF THE EFFICACY, SAFETY AND TOLERABILITY OF THE CONCURRENT ADMINISTRATION OF CHF 4226 HFA pMDI AND EXTRAFINE BUDESONIDE HFA pMDI, BOTH GIVEN ONCE OR TWICE DAILY (2μg + 200μg qd or 1μg + 100μg bid) OVER AN 8-WEEK RANDOMIZED DOUBLE-BLIND TREATMENT PERIOD IN ADULT PATIENTS WITH MODERATE PERSISTENT ASTHMA AND PRESENTING WITH SYMPTOMS ON EXISTING INHALED CORTICOSTEROID THERAPY.

Completed
2
304
Europe
CHF 4226 HFA pMDI, Extrafine Budesonide HFA pMDI, Pulmicort Turbuhaler, CHF 4226 HFA, BUD-EF HFA,
CHIESI Farmaceutici S.p.A
Moderate persistent asthma sub optimally controlled on existing therapy.
 
02/07

Download Options